Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
The diagnosis moment: – the role of POCT HbA1c in undiagnosed diabetes and prediabetes in plowing the progression of diabetes and improving health equ...
American Diabetes Association
Diabetes Care, 2020
A publicação de Standards of Medical Care in Diabetes, da American Diabetes Association (ADA), descreve as recomendações atuais de práticas clínicas para os cuidados com diabetes, incluindo metas de tratamento, ferramentas para avaliar a qualidade dos cuidados e recomendações para o monitoramento do perfil lipídico (que pode ser realizado por meio de testes no POC). As diretrizes rec...
Doenças cardiovasculares e gerenciamento de risco: padrões de cuidados em diabetes – 2020
Em nossa série de artigos de destaque, analisamos publicações de relevância sobre os testes no local de prestação de cuidados de saúde (POCT), fornecendo resumos e comentários de especialistas sobre os principais aspectos do artigo e dentro do contexto mais amplo dos sistemas de POCT.
Neste artigo, abordamos a publicação abaixo, feita pelo Dr. El Osta e coautores:
Does use of point-of-care testing improve cost-effect...
Testes no local de prestação de cuidados de saúde para melhorar a relação de custo-benefício dos programas de exame de saúde nos cuidados primários
Join our panel of experts from around the world to learn about Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabetes and non diabetes patients. The webinar will analyse studies and present front line experience on the value of point of care testing told through the eyes of internationally acclaimed health care professionals and academics from Ge...
Manejo de doenças crônicas na era pós-COVID - o valor do teste no local de atendimento para risco cardiovascular e manejo de doenças renais em pacient...
Erna Lenters-Westra e Emma English
Journal of Diabetes Science and Technology 2018;12(4):762-770
Dada a importância do teste no local de prestação de cuidados de saúde (POCT), Lenters-Westra e English investigam os critérios de qualidade usados para avaliar os dispositivos de POCT para estabelecer se possuem o mesmo padrão de desempenho dos principais analisadores de laboratório. Eles aplicam os protocolos EP-5 e EP-9 do Clinical a...
Avaliação de quatro dispositivos POC de HbA1c usando metas internacionais de qualidade: eles são adequados ao objetivo?
Vincent Delatour, Noémie Clouet-Foraisona, Stéphane Jaisson, Patricia Kaiser e Philippe Gillery
Clinical Chemistry and Laboratory Medicine 2019;25(57)10:1623-1631
Neste artigo, Delatour e coautores exploram a veracidade dos programas de avaliação externa da qualidade (EQA) para determinar a exatidão dos testes de HbA1c em diabetes (tanto em laboratório quanto em sistemas de locais de prestação de cuidados de saúde). A comutabilidade...
Avaliação da veracidade dos ensaios de rotina de HbA1c: os materiais EQA processados estão à altura do trabalho?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Should you screen for kidney damage? What do the guidelines say?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
The value of POCT in SMI health checks and patients with learning disabilities for the diagnosis, management and monitoring of diabetes and cardiovasc...
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
Diabetic kidney disease, and chronic kidney disease attributed to diabetes, occurs in 20-40% of patients with diabetes. Acute kidney injury is also one of the most significant complications associated with COVID-19. Point-of-care testing for albumin-creatinine ratio is a valuable tool for monitoring at-risk patients, especially in combination with other comorbid parameters, such as HbA1c and lipids.
ACR point-of-care testing for diabetic kidney disease
The International Diabetes Federation (IDF) published an updated version of its flagship ‘Diabetes Atlas’ in 2019. The atlas covers evidence on the impact of diabetes worldwide, including recommendations for testing and screening.
IDF testing and screening recommendations for diabetes from the 2019 Diabetes Atlas
This clinical practice guideline from the American Heart Association (AHA) aims to give healthcare
providers consistent, clear, and evidence-based guidance for treating patients at risk for atherosclerotic
cardiovascular disease (ASCVD)
AHA cholesterol management guideline for healthcare practitioners
This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).
ACC / AHA guideline on the primary prevention of cardiovascular disease
The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.
WHO guidelines on second-and third-line medicines and type of insulin for blood glucose control in diabetes
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.
KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease
Dr. Erna Lenters-Westra, from the Department of Clinical Chemistry, Isala, Zwolle, The Nederlands, talks about HbA1c point-of-care testing, its advantages and perfomance-wise perspective.
HbA1c point-of-care testing: performance and advantages
Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way
Cardiovascular risk assessment and prevention: where do we stand?
Cardiovascular diseases are a leading cause of death globally, taking 17.9 million lives each year1. Patients at risk of cardiovascular disease (CVD) may show raised blood pressure, have diabetes or have high lipid levels. The good news is, reducing the risk of cardiovascular disease (such as dyslipidemia, hypercholesterolemia and hypertriglyceridemia) is possible with lipid panel tests to identify risk, and continued testing for monitoring.
A one stop shop: the impact of point-of-care lipid testing on cardiovascular disease screening and management
The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) European Heart Journal 2020;42:255-323
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
The EurA1c Trial GroupClinical Chemistry 2018;64(8):1183-1192The aim of this extensive study was to generate awareness and improvement of HbA1c assays through evaluation of performance by countries and by manufacturers. Analytical performance of 2166 laboratories were evaluated across 17 countries and 24 manufacturers, of which 22 were laboratory systems and two were point-of-care (POC) systems, according to International Federation of Clinical C...
EurA1c: the European HbA1c trial to investigate the performance of HbA1c assays
NGSP and the College of American Pathologists (CAP), 2020The American Diabetes Association (ADA) recommends that HbA1c tests should be performed using a method that is certified by NGSP. Participation in a proficiency testing survey (external quality assessment), such as the CAP GH5 fresh whole blood HbA1c program, allows individual laboratories to compare their performance against peer groups and against the target values assigned by NGSP.
GH5 proficiency survey data for standardisation of HbA1c testing
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 4 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
Hear expert opinion on the use of CRP POCT for COVID-19 management and reduction of antimicrobial resistance
Check out the on-demand educational recording from Africa Online Healthcare Week 2020 by clicking here. Dr Susanne Emmerich (Germany) discusses the relationship between diabetes and COVID-19, and how HbA1c point-of-care testing (POCT) impacts glycemic control in diabetic patients. Dr Carl Llor (Spain) discusses the value of C-reactive protein (CRP) POCT to aid assessment of COVID-19 and prevent unnecessary prescription of antibiotics.
View expert presentation on point-of-care testing for diabetes and in the context of COVID-19
Africa Healthcare Week Online is the largest ever virtual event for African healthcare. It features thousands of attendees, with over 80 webinar speakers, including panel discussions and case studies from ministries of health and prominent healthcare leaders.
Africa Healthcare Week Online
en
Acesse agora
Sem mais resultados
By using this site, you agree with our use of cookies.
